See also this year's filing and all EDGAR filings for this company.
PDF Report 0000316253_2021_ENZO_Biochem_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0000316253')"} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0000316253, ENZO Biochem INC
| xvar | xval | |
|---|---|---|
| 0 | IntangibleAssets | 7,990,000 |
| 1 | AssetsNonCurrent | 21,301,000 |
| 2 | AssetsCurrent | 68,765,000 |
| 3 | PropertyPlantAndEquipment | 14,482,000 |
| 4 | remainder_Assets | 0 |
| 5 | LongTermLiabilities | 21,356,000 |
| 6 | LiabilitiesCurrent | 32,801,000 |
| 7 | remainder_Liabilities | 0 |
| 8 | LaborExpense | 0 |
| 9 | CostOfGoodsAndServicesSold | 52,251,000 |
| 10 | GeneralAndAdministrativeExpense | 42,960,000 |
| 11 | GoodwillImpairmentLoss | 0 |
| 12 | OperatingCostsAndExpenses | 0 |
| 13 | DepreciationDepletionAndAmortization | 0 |
| 14 | SellingAndMarketingExpense | 0 |
| 15 | ResearchAndDevelopmentExpense | 4,448,000 |
| 16 | remainder_Expenses | 6,729,000 |
| 17 | remainder_Revenues | 76,021,000 |
| 18 | remainder_NetIncome | 1,847,000 |
| 19 | remainder_ComprehensiveNetIncome | -899,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 112,538,000 |
| 1 | Liabilities | 54,157,000 |
| 2 | Expenses | 106,388,000 |
| 3 | Revenues | 76,021,000 |
| 4 | StockholdersEquity | 58,381,000 |
| 5 | NetIncome | -28,520,000 |
| 6 | ComprehensiveNetIncome | -29,419,000 |
| 7 | BaseVar | 175,925,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.663 |
| 9 | EconomicCapitalRatio | 1.46 |
Edgar->Model Mapping
Feature Distribution
Change over Time
